Does cytochrome 2D6 genotype affect the analgesic efficacy of codeine after ambulatory surgery? Prospective trial in 987 adults
Acta Anaesthesiologica Scandinavica · 2025
DOI: 10.1111/aas.14549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2025. Verfasst von Satu Poikola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Perioperative and Intensive Care, Helsinki University Hos…. Hauptthemen laut MEDLINE: Codeine, Cytochrome P-450 CYP2D6, Ambulatory Surgical Procedures, Genotype. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Governmental Research Funds for University Level Health Research, Helsinki University Hospital Research Funds.
Abstract (Originalsprache)
Background
Paracetamol–codeine combination tablet is widely used in pain management after day surgery. For safety reasons, its use has decreased in recent years. Codeine is a prodrug metabolised in the liver by the cytochrome P450 2D6 (CYP2D6) enzyme to morphine that produces the analgesic effect of codeine. CYP2D6 is highly polymorphic, and based on genotypes, individuals can be divided into four categories: poor‐, intermediate‐, normal‐ and ultrarapid metabolisers. Differences in morphine and its metabolite concentrations have been described between different CYP2D6 genotypes following codeine administration. The aim of the study was to investigate the possible effect of CYP2D6 genotype on codeine efficacy and adverse effects in a large cohort of adult patients undergoing ambulatory surgery.
Methods
A total of 987 patients scheduled for ambulatory surgery were included in the analyses. Operation types or anaesthesia methods were not limited in the study protocol. All study patients received a fixed dose of paracetamol (1000 mg) and codeine (60 mg) orally for premedication. A blood sample was drawn to identify the genotype of CYP2D6. At home, the first‐line analgesic was paracetamol–codeine combination of 1–2 tablets at 1–3 times per day. Data on the efficacy and side effects of codeine were collected on the day of surgery and the following two postoperative days.
Results
Of the studied patients, 37 (3.7%) were poor CYP2D6 metabolisers, 264 (27%) were intermediate, 623 (63%) were normal and 63 (6.4%) were ultrarapid metabolisers. Activity scores ranged from 0 to 4. CYP2D6 genotype was not associated in a statistically significant manner with postoperative pain, opioid consumption or the adverse effects of codeine, except for constipation at home. Poor CYP2D6 metabolisers reported significantly less severe constipation compared with normal metabolisers ( p = .009, OR 0.40, 95% Cl 0.20–0.80).
Conclusion
CYP2D6 genotype appears to be of minor importance for the analgesic efficacy of oral paracetamol‐codeine combination therapy after ambulatory surgery in adult patients undergoing similar types of surgery as in the present study but it may affect the risk of constipation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Perioperative and Intensive Care, Helsinki University Hospital, Helsinki, Finland.
- Gastroenterological surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Clinical Pharmacology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
- Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Terveystalo Hospital, Helsinki, Finland.
- Department of Pharmacology, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Satu Poikola, Hanna von Plato
Förderung
- Governmental Research Funds for University Level Health Research
- Helsinki University Hospital Research Funds
Zitieren
APA
Poikola, S., von Plato, H., Harju, J., Kiiski, J. I., Mattila, K., Olkkola, K. T., Niemi, M., Kalso, E., & Kontinen, V. (2025). Does cytochrome 2D6 genotype affect the analgesic efficacy of codeine after ambulatory surgery? Prospective trial in 987 adults. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14549
Vancouver
Poikola S, von Plato H, Harju J, Kiiski JI, Mattila K, Olkkola KT, et al. Does cytochrome 2D6 genotype affect the analgesic efficacy of codeine after ambulatory surgery? Prospective trial in 987 adults. Acta Anaesthesiologica Scandinavica. 2025. doi:10.1111/aas.14549
BibTeX
@article{Poikola2025,
author = {Poikola, Satu and von Plato, Hanna and Harju, Jukka and Kiiski, Johanna I and Mattila, Kristiina and Olkkola, Klaus T and Niemi, Mikko and Kalso, Eija and Kontinen, Vesa},
title = {Does cytochrome 2D6 genotype affect the analgesic efficacy of codeine after ambulatory surgery? Prospective trial in 987 adults},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2025},
doi = {10.1111/aas.14549}
}
EUVIMED